Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TrueBlue, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
2,751
2,509
2,499
2,369
1,846
2,174
2,254
1,906
1,567
1,616
Cost of revenue
2,071
1,874
1,844
1,749
1,406
1,613
1,652
1,400
1,161
1,248
Gross profit
680
634
655
620
441
560
602
506
406
368
Selling, general and administrative
546
511
540
516
408
464
501
495
411
371
Operating income
-17
77.6
73.9
66.2
-175
68.4
72.2
-23.9
-92.8
-46.6
Interest expense
7.17
5.49
4.88
2.78
Other non-operating income
-3.35
-0.01
1.74
3.87
Pre-tax income
-20.3
77.6
75.7
70
-173
73.9
73.4
-20.6
-88.5
-45.6
Income tax
-5.09
22.1
9.91
6.97
-31.4
12.2
11.1
-6.47
37.2
2.33
Net income
-15.3
55.5
65.8
63.1
-142
61.6
62.3
-14.2
-126
-48
EBITDA
29.7
124
115
104
-143
96
101
1.97
-63.2
-17.8
EPS, basic
-0.37
1.35
1.64
1.63
-4.01
1.77
1.89
-0.45
-4.17
-1.61
EPS, diluted
-0.37
1.34
1.63
1.61
-4.01
1.74
1.86
-0.45
-4.17
-1.61
Shares, basic (weighted)
41.6
41.2
40
38.8
35.4
34.8
32.9
31.3
30.2
29.8
Shares, diluted (weighted)
41.6
41.4
40.3
39.2
35.4
35.4
33.4
31.3
30.2
29.8
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
35
28.8
47
37.6
62.5
49.9
72.1
61.9
22.5
24.5
Receivables
353
374
355
342
278
354
314
253
215
241
Other current assets
21.4
20.6
22.1
13.4
8.86
12.7
13.1
6.26
5.2
4.75
Total current assets
428
428
430
422
379
445
430
355
277
298
Property, plant and equipment
64
60.2
57.7
66.2
71.7
88.1
95.8
105
89.6
73.1
Lease right-of-use assets
0
41.1
65.9
55.2
50.8
49.8
47.3
34
Goodwill
224
227
237
237
94.9
94.5
93.8
84.1
24.5
42.5
Intangible assets
126
105
91.4
73.7
28.9
22.2
16.2
10.5
5.86
18.1
Other non-current assets
50.8
1.22
13.9
17.2
16.7
16.4
17.8
12.7
11.8
9.72
Total assets
1,130
1,109
1,115
1,136
981
1,033
1,019
899
675
639
Accounts payable
66.8
55.1
62
68.4
58.4
77.2
76.6
56.4
45.6
36.1
Accrued liabilities
79.8
76.9
77.1
67.6
Deferred revenue
1.17
0.63
3.81
1.84
1.72
Short-term debt
2.27
0
Total current liabilities
251
212
226
231
269
259
243
204
160
139
Long-term debt
135
116
80
37.1
0
0
0
7.6
65.8
Lease liabilities
0
28.8
54.8
54.9
50.6
49.4
47.8
46.8
Other non-current liabilities
5.6
6.31
6.11
4.06
3.78
3.28
2.4
1.12
1.32
0.9
Total liabilities
605
554
523
510
543
540
523
442
360
364
Total debt
138
119
80
37.1
0
0
0
7.6
65.8
Retained earnings
537
562
606
639
452
509
516
479
338
296
Other comprehensive income
-11.4
-6.8
-14.6
-13.2
-14.8
-15.7
-20
-20.7
-22.2
-21.6
Shareholders' equity
525
555
591
626
437
493
496
458
315
275
Total equity
525
555
591
626
437
493
496
458
315
275
Total liabilities and equity
1,130
1,109
1,115
1,136
981
1,033
1,019
899
675
639
Shares outstanding
42.2
41.1
40.1
38.6
35.5
34.9
32.7
31.2
29.6
30
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-15.3
55.5
65.8
63.1
-142
61.6
62.3
-14.2
-126
-48
Depreciation and amortization
46.7
46.1
41
37.5
32
27.6
29.3
25.8
29.6
28.9
Stock-based compensation
9.36
7.74
13.9
9.77
9.11
13.9
9.69
13.9
7.59
7.26
Deferred income tax
-25.4
2.44
-1.93
1.26
-26.8
0.75
3.93
-9.9
34.1
-0.55
Change in receivables
113
-28.5
11.6
5.45
57.1
-81.6
34.8
56.8
35.7
-15.5
Cash from operations
261
100
126
93.5
153
20.4
121
34.8
-17.1
-58
Capital expenditures
-29
-22
-17.1
-28.1
-27.1
-35
-30.6
-31.3
-24.2
-15.7
Acquisitions
-72.5
0
-22.7
0
0
0
0
-30.1
Purchases of investments
0
Sales and maturities of investments
0
0
Cash from investing
-124
-54.4
-20.5
-21.6
-34.4
-16.2
-20.9
-32.3
-2.45
-16.1
Share buybacks
-5.75
-36.7
-34.8
-38.8
-52.3
-16.7
-60.9
-34.2
-21.3
0
Cash from financing
-115
-75.3
-75
-82.9
-92.5
-19.1
-64.7
-37.6
-17.1
57.1
Exchange rate effect
1.77
0.19
-1.54
0.94
0.62
-0.52
-2.42
-0.87
-1.61
-0.12
Net change in cash
23.4
-29.4
28.6
-10.1
26.2
-15.4
32.4
-36.3
-38.2
-17.1
Free cash flow
232
78.2
109
65.4
125
-14.6
89.9
3.48
-41.2
-73.7
Interest paid
4.08
3.81
4.37
2.43
3.15
1.43
1.12
1.03
1.04
4.62
Income taxes paid
10.3
4.59
12.9
12.2
-3.44
9.77
9.98
5.17
0.21
-4.85
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $9.44 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
21.2%
Gross profit / revenue.
Operating margin
-2.9%
Operating income / revenue.
EBITDA margin
-1.3%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-3.2%
Pre-tax income / revenue.
Net margin
-3.3%
Net income / revenue.
FCF margin
-4.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-3.2%
Cash from operations / revenue.
Return on equity (ROE)
-22.2%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-9.1%
Net income / average total assets.
Return on invested capital (ROIC)
-12.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
21.2%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.4%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.8%
Capital expenditures / revenue.
D&A / revenue
1.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
3.1%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-10.5%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-2.6%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-9.5%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-15.1%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-3.5%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-12.9%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-17.9%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-8.9%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-5.4%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-14.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-8.2%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
-1.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-3.7%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-3.3%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.28x
Current assets / current liabilities.
Quick ratio
2.09x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.17x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.32x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
13.2%
Total debt / total assets.
Liabilities / assets
59.1%
Total liabilities / total assets.
Net debt
$59.1M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$55.60
Revenue / diluted weighted shares.
FCF per share
-$2.22
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$1.79
Cash from operations / diluted weighted shares.
Book value per share
$8.37
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.17x
Market cap / revenue.
P/B
1.13x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
1.44x
Market cap / tangible book value, when positive.
EV/Sales
0.20x
Enterprise value / revenue.
FCF yield
-23.5%
Free cash flow / market cap.
Earnings yield
-19.7%
Net income / market cap (the inverse of P/E).
What was TrueBlue, Inc.'s revenue in fiscal 2025?
TrueBlue, Inc. reported revenue of $1.62B for fiscal 2025, 3.1% higher than the year before.
Was TrueBlue, Inc. profitable in fiscal 2025?
No. It reported a net loss of $48.0M.
How much free cash flow did TrueBlue, Inc. generate in fiscal 2025?
Cash from operations of $58.0M minus capital expenditures of $15.7M left free cash flow of -$73.7M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.